CustomVis

Perth, Australia Founded: 2001 • Age: 25 yrs Listed
Surgical laser vision correction technology is provided for ophthalmologists.

About CustomVis

CustomVis is a publicly listed company based in Perth (Australia) founded in 2001. It operates as a surgical laser vision correction technology is provided for ophthalmologists. Its chief executive is Mukesh Jain. CustomVis offers products and services including PULZAR TM Z1. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is CV Laser Pty Ltd. Its competitors include Clerio Vision, IntraLase, Kejako, Technolas Perfect Vision and WaveLight and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

Founded in 2001 in Perth, Australia, CustomVis focuses on ophthalmology technology. A solid-state refractive laser system has been developed for surgical vision correction procedures. Customized ablation profiles are enabled by a 0.6mm flying beam spot size, while a 300-400 Hz pulse rate supports efficient treatment durations. Pupil dilation requirements are avoided, and decentration risks are minimized through these operational features.

  • Headquarters Perth, Australia
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website customvis.com
  • Social LinkedIn X
  • Legal Name Cv Laser Pty Ltd
Operational Areas

Products & Services of CustomVis

CustomVis offers a comprehensive portfolio of products and services, including PULZAR TM Z1.

PULZAR TM Z1
Laser System

Solid-state laser for accurate vision correction surgery

People of CustomVis

1 people are tracked at CustomVis (1 in leadership).

NameRoleGroup
Mukesh Jain
Chairman & CEOLeadership
Premium access

Complete people profiles for CustomVis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of CustomVis

CustomVis has 9 listed competitors in our database, 4 of them funded. They include Clerio Vision, IntraLase, Kejako, Technolas Perfect Vision and WaveLight, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cleriovision.com2014Rochester, United States$28.95M90
Laser induced change in refractive index
intralase.com1997Irvine, United States$29.5M–
Femtosecond laser technology is developed for eye surgery procedures.
kejako.com2015–$807,476–
Medical devices for ophthalmic surgery are researched and developed.
technolaspv.com2008Munich, Germany–163
Femtosecond and excimer lasers for ophthalmology are designed and produced.
wavelight.de1996Erlangen, Germany–320
Diagnostic and surgical technologies for vision correction are provided.
xianweivisiontechnology.tcc.mode2022Nanjing, China––
Femtosecond laser-based devices for ophthalmic myopia correction are developed.
lenticularresearchgroup.com2007Naperville, United States$330,000–
Developer of laser device for treating the cause of presbyopia
optotek-medical.com1990Ljubljana, Slovenia––
Optical and laser solutions for ophthalmic treatments are developed.
tklaser.com2006Tianjin, China––
Manufactures and supplies medical lasers.
Premium access

Detailed competitors of CustomVis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CustomVis

The website of CustomVis (customvis.com) receives about 1K visits a month.

  • Monthly visits
    1K

    ▼ 38.5% vs previous month

Top companies in Ophthalmology

10 companies that operate in the same segment as CustomVis (Ophthalmology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 9.64 B25,600
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M–100
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
2003Alpharetta, Georgia, United StatesUSD 66.8 MUSD 80.75 M79
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
2009Bengaluru, Karnataka, IndiaUSD 25.01 MUSD 4.85 M135
Gene therapies for ocular and neurodegenerative diseases are developed.
2015New York, New York, United States–USD 81.39 M381
Small molecule therapeutics for ophthalmic disorders are developed.
1987Watertown, United States–USD 31.37 M165
Therapies for metabolic and orphan diseases are developed by Rezolute.
2012Denver, Colorado, United States––59
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
2010Bengaluru, Karnataka, IndiaUSD 18.12 MUSD 4.78 M145
Therapeutics for retinal diseases are developed by the company.
2009Palo Alto, California, United StatesUSD 35.84 M–109
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about CustomVis

CustomVis was founded in 2001.

CustomVis is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.

Mukesh Jain is the current CEO of CustomVis.

Founded in 2001 in Perth, Australia, CustomVis focuses on ophthalmology technology. A solid-state refractive laser system has been developed for surgical vision correction procedures. Customized ablation profiles are enabled by a 0.6mm flying beam spot size, while a 300-400 Hz pulse rate supports efficient treatment durations. Pupil dilation requirements are avoided, and decentration risks are minimized through these operational features.

CustomVis's top competitors include Clerio Vision, IntraLase and WaveLight.

CustomVis offers PULZAR TM Z1.

CustomVis operates through Cv Laser Pty Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available